These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16639914)

  • 21. Meniett device for Ménière's disease: use and compliance at 3 to 5 years.
    Mattox DE; Reichert M
    Otol Neurotol; 2008 Jan; 29(1):29-32. PubMed ID: 18199955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of the Meniett device in Japanese patients with Meniere's disease and delayed endolymphatic hydrops reported by the Middle Ear Pressure Treatment Research Group of Japan.
    Shojaku H; Watanabe Y; Mineta H; Aoki M; Tsubota M; Watanabe K; Goto F; Shigeno K
    Acta Otolaryngol; 2011 Mar; 131(3):277-83. PubMed ID: 21319947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of static middle-ear and intracranial pressure changes on differential electrocochleographic response.
    Franz B; Anderson C
    Int Tinnitus J; 2008; 14(2):101-7. PubMed ID: 19205159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral Ménière's disease.
    Nabi S; Parnes LS
    Curr Opin Otolaryngol Head Neck Surg; 2009 Oct; 17(5):356-62. PubMed ID: 19617826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transtympanic gentamycin in the treatment of Ménière's disease.
    Lange G
    Rev Laryngol Otol Rhinol (Bord); 1995; 116(2):151-2. PubMed ID: 7569379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical long-term effects of Meniett pulse generator for Meniere's disease.
    Huang W; Liu F; Gao B; Zhou J
    Acta Otolaryngol; 2009 Aug; 129(8):819-25. PubMed ID: 18923942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of transtympanic intermittent pressure therapy using a new tympanic membrane massage device for intractable Meniere's disease and delayed endolymphatic hydrops: a prospective study.
    Shojaku H; Aoki M; Takakura H; Fujisaka M; Asai M; Tsubota M; Ito Y; Watanabe Y
    Acta Otolaryngol; 2021 Oct; 141(10):907-914. PubMed ID: 34520288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vestibular neurectomy vs. chemical labyrinthectomy in the treatment of disabling Menière's disease: a long-term comparative study.
    Schmerber S; Dumas G; Morel N; Chahine K; Karkas A
    Auris Nasus Larynx; 2009 Aug; 36(4):400-5. PubMed ID: 19026499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ozone therapy and pressure-pulse therapy in Ménière's disease.
    Pawlak-Osińska K; Kaźmierczak H; Kaźmierczak W; Szpoper M
    Int Tinnitus J; 2004; 10(1):54-7. PubMed ID: 15379351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vestibulo-ocular reflex characteristics in patients with unilateral Ménière's disease.
    Maire R; van Melle G
    Otol Neurotol; 2008 Aug; 29(5):693-8. PubMed ID: 18520629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relevance of an elevation in the plasma vasopressin levels to the pathogenesis of Meniere's attack.
    Aoki M; Asai M; Nishihori T; Mizuta K; Ito Y; Ando K
    J Neuroendocrinol; 2007 Nov; 19(11):901-6. PubMed ID: 17927668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratympanic application of an antiviral agent for the treatment of Ménière's disease.
    Guyot JP; Maire R; Delaspre O
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(1):21-6; discussion 26-7. PubMed ID: 18235202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K; Schönfeld U; Clarke AH
    Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meniett therapy may avoid vestibular neurectomy in disabling Meniere's disease.
    Barbara M; Monini S; Chiappini I; Filipo R
    Acta Otolaryngol; 2007 Nov; 127(11):1136-41. PubMed ID: 17851896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring pressure changes in the inner ear induced by middle ear pressure therapy with an EFET01 device in guinea pigs.
    Tram Anh D; Takakura H; Nakazato A; Shojaku H
    Acta Otolaryngol; 2023 Aug; 143(8):655-661. PubMed ID: 37537955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lateral semicircular canal plugging: a simple and effective surgical treatment against incapacitating Menière's disease.
    Gentine A; Martin E; Schultz P; Debry C; Charpiot A
    Rev Laryngol Otol Rhinol (Bord); 2008; 129(1):11-6. PubMed ID: 18777764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of endolymphatic sac drainage with steroids for intractable Meniere's disease: a long-term follow-up and randomized controlled study.
    Kitahara T; Kubo T; Okumura S; Kitahara M
    Laryngoscope; 2008 May; 118(5):854-61. PubMed ID: 18520184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time course of episodes of definitive vertigo in Meniere's disease.
    Perez-Garrigues H; Lopez-Escamez JA; Perez P; Sanz R; Orts M; Marco J; Barona R; Tapia MC; Aran I; Cenjor C; Perez N; Morera C; Ramirez R
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1149-54. PubMed ID: 19015442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.